QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (111) Citing Articles via Google Scholar Google Scholar Articles by Emerich, D. F. Articles by Kordower, J. H. Search for Related Content PubMed PubMed Citation Articles by Emerich, D. F. Articles by Kordower, J. H.

 Previous Article  |  Next Article 

Volume 16, Number 16, Issue of August 15, 1996 pp. 5168-5181
Copyright ©1996 Society for Neuroscience

Implants of Encapsulated Human CNTF-Producing Fibroblasts Prevent Behavioral Deficits and Striatal Degeneration in a Rodent Model of Huntington's Disease

Received March 25, 1996; revised May 17, 1996; accepted May 30, 1996.

Dwaine F. Emerich¹, Mark D. Lindner¹, Shelley R. Winn¹, Er-Yun Chen², Beata R. Frydel¹, and Jeffrey H. Kordower¹

¹ CytoTherapeutics, Inc., Providence, Rhode Island 02906, and ² Research Center for Brain Repair and Department of Neurological Sciences, Rush Presbyterian Medical Center, Chicago, Illinois 60612

Delivery of neurotrophic molecules to the CNS has gained considerable attention as a potential treatment strategy for neurological disorders. In the present study, a DHFR-based expression vector containing the human ciliary neurotrophic factor (hCNTF) was transfected into a baby hamster kidney fibroblast cell line (BHK). Using a polymeric device, encapsulated BHK-control cells and those secreting hCNTF (BHK-hCNTF) were transplanted unilaterally into the rat lateral ventricle. Twelve days later, the same animals received unilateral injections of quinolinic acid (QA; 225 nmol) into the ipsilateral striatum. After surgery, animals were behaviorally tested for apomorphine-induced rotation behavior and for skilled forelimb function using the staircase test. Rats receiving BHK-hCNTF cells rotated significantly less than animals receiving BHK-control cells. No behavioral effects of hCNTF were observed on the staircase test. Nissl-stained sections demonstrated that BHK-hCNTF cells significantly reduced the extent of striatal damage produced by QA. Quantitative analysis of striatal neurons further demonstrated that both choline acetyltransferase- and GAD-immunoreactive neurons were protected by BHK-hCNTF implants. In contrast, a similar loss of NADPH-diaphorase-positive cells was observed in the striatum of both implant groups. Analysis of retrieved capsules revealed numerous viable and mitotically active BHK cells that continued to secrete hCNTF. These results support the concepts that implants of polymer-encapsulated hCNTF-releasing cells can be used to protect striatal neurons from excitotoxic damage and that this strategy may ultimately prove relevant for the treatment of Huntington's disease.

Key words: polymer encapsulation; Huntington's disease; CNTF; neurotrophic factor; transplantation; quinolinic acid; fibroblasts; genetic modification

This article has been cited by other articles:

				P. A. Sieving, R. C. Caruso, W. Tao, H. R. Coleman, D. J. S. Thompson, K. R. Fullmer, and R. A. Bush Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants PNAS, March 7, 2006; 103(10): 3896 - 3901. [Abstract] [Full Text] [PDF]

				C. V. Borlongan, S. J.M. Skinner, M. Geaney, A. V. Vasconcellos, R. B. Elliott, and D. F. Emerich Intracerebral Transplantation of Porcine Choroid Plexus Provides Structural and Functional Neuroprotection in a Rodent Model of Stroke Stroke, September 1, 2004; 35(9): 2206 - 2210. [Abstract] [Full Text] [PDF]

				M. Peschanski, A.-C. Bachoud-Levi, and P. Hantraye Integrating fetal neural transplants into a therapeutic strategy: the example of Huntington's disease Brain, June 1, 2004; 127(6): 1219 - 1228. [Abstract] [Full Text] [PDF]

				H. C. Salzberg-Brenhouse, E.-Y. Chen, D. F. Emerich, S. Baldwin, K. Hogeland, S. Ranelli, D. Lafreniere, B. Perdomo, L. Novak, T. Kladis, et al. Inhibitors of Cyclooxygenase-2, but Not Cyclooxygenase-1 Provide Structural and Functional Protection against Quinolinic Acid-Induced Neurodegeneration J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 218 - 228. [Abstract] [Full Text] [PDF]

				W. Tao, R. Wen, M. B. Goddard, S. D. Sherman, P. J. O'Rourke, P. F. Stabila, W. J. Bell, B. J. Dean, K. A. Kauper, V. A. Budz, et al. Encapsulated Cell-Based Delivery of CNTF Reduces Photoreceptor Degeneration in Animal Models of Retinitis Pigmentosa Invest. Ophthalmol. Vis. Sci., October 1, 2002; 43(10): 3292 - 3298. [Abstract] [Full Text] [PDF]

				V. Mittoux, S. Ouary, C. Monville, F. Lisovoski, T. Poyot, F. Conde, C. Escartin, R. Robichon, E. Brouillet, M. Peschanski, et al. Corticostriatopallidal Neuroprotection by Adenovirus-Mediated Ciliary Neurotrophic Factor Gene Transfer in a Rat Model of Progressive Striatal Degeneration J. Neurosci., June 1, 2002; 22(11): 4478 - 4486. [Abstract] [Full Text] [PDF]

				F. Lisovoski, S. Akli, E. Peltekian, E. Vigne, G. Haase, M. Perricaudet, P. A. Dreyfus, A. Kahn, and M. Peschanski Phenotypic Alteration of Astrocytes Induced by Ciliary Neurotrophic Factor in the Intact Adult Brain, As Revealed by Adenovirus-Mediated Gene Transfer J. Neurosci., October 1, 1997; 17(19): 7228 - 7236. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help